253 related articles for article (PubMed ID: 28716439)
21. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
[TBL] [Abstract][Full Text] [Related]
22. SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Vokshi BH; Davidson G; Tawanaie Pour Sedehi N; Helleux A; Rippinger M; Haller AR; Gantzer J; Thouvenin J; Baltzinger P; Bouarich R; Manriquez V; Zaidi S; Rao P; Msaouel P; Su X; Lang H; Tricard T; Lindner V; Surdez D; Kurtz JE; Bourdeaut F; Tannir NM; Davidson I; Malouf GG
Nat Commun; 2023 May; 14(1):3034. PubMed ID: 37236926
[TBL] [Abstract][Full Text] [Related]
23. Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes.
Carlo MI; Chaim J; Patil S; Kemel Y; Schram AM; Woo K; Coskey D; Nanjangud GJ; Voss MH; Feldman DR; Hsieh JJ; Hakimi AA; Chen YB; Motzer RJ; Lee CH
Clin Genitourin Cancer; 2017 Dec; 15(6):e987-e994. PubMed ID: 28558987
[TBL] [Abstract][Full Text] [Related]
24. Renal medullary carcinoma in a white adolescent with sickle cell trait.
Daher P; Bourgi A; Riachy E; Khoury A; Rehayem C; Sader-Ghorra C
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e285-9. PubMed ID: 24517963
[TBL] [Abstract][Full Text] [Related]
25. Renal medullary carcinoma involving serous cavity fluids: a cytomorphologic study of 12 cases.
Miller DL; Ribeiro EA; Roy-Chowdhuri S; Illei PB; Siddiqui MT; Ali SZ
J Am Soc Cytopathol; 2021; 10(2):187-196. PubMed ID: 32651128
[TBL] [Abstract][Full Text] [Related]
26. Renal Medullary Carcinoma and Sickle Cell Trait: A Push for Early Diagnosis and Intervention Report of Two Cases.
Carter SA; Walker AN
J Natl Med Assoc; 2017 Spring; 109(1):63-65. PubMed ID: 28259220
[TBL] [Abstract][Full Text] [Related]
27. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications.
Swartz MA; Karth J; Schneider DT; Rodriguez R; Beckwith JB; Perlman EJ
Urology; 2002 Dec; 60(6):1083-9. PubMed ID: 12475675
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and Molecular Pathology of Collecting Duct Carcinoma and Related Renal Cell Carcinomas.
Seo AN; Yoon G; Ro JY
Adv Anat Pathol; 2017 Mar; 24(2):65-77. PubMed ID: 28181950
[TBL] [Abstract][Full Text] [Related]
29. Renal Medullary Carcinoma: a Report of the Current Literature.
Blas L; Roberti J; Petroni J; Reniero L; Cicora F
Curr Urol Rep; 2019 Jan; 20(1):4. PubMed ID: 30656488
[TBL] [Abstract][Full Text] [Related]
30. Diagnosing colorectal medullary carcinoma: interobserver variability and clinicopathological implications.
Lee LH; Yantiss RK; Sadot E; Ren B; Calvacanti MS; Hechtman JF; Ivelja S; Huynh B; Xue Y; Shitilbans T; Guend H; Stadler ZK; Weiser MR; Vakiani E; Gönen M; Klimstra DS; Shia J
Hum Pathol; 2017 Apr; 62():74-82. PubMed ID: 28034727
[TBL] [Abstract][Full Text] [Related]
31. Clear cell-papillary renal cell carcinoma of the kidney not associated with end-stage renal disease: clinicopathologic correlation with expanded immunophenotypic and molecular characterization of a large cohort with emphasis on relationship with renal angiomyoadenomatous tumor.
Aron M; Chang E; Herrera L; Hes O; Hirsch MS; Comperat E; Camparo P; Rao P; Picken M; Michal M; Montironi R; Tamboli P; Monzon F; Amin MB
Am J Surg Pathol; 2015 Jul; 39(7):873-88. PubMed ID: 25970682
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of morphologically unclassified renal cell carcinoma with electron microscopy and novel renal markers: implications for tumor reclassification.
Talento R; Hewan-Lowe K; Yin M
Ultrastruct Pathol; 2013 Feb; 37(1):70-6. PubMed ID: 23383617
[TBL] [Abstract][Full Text] [Related]
33. Renal medullary carcinoma metastatic to the orbit: a clinicopathologic report.
Zdinak LA; Nik NA; Hidayat AA; Hargett NA
Ophthalmic Plast Reconstr Surg; 2004 Jul; 20(4):322-5. PubMed ID: 15266151
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of SMARCB1/INI-1 expression in collecting duct carcinoma.
Elwood H; Chaux A; Schultz L; Illei PB; Baydar DE; Billis A; Sharma R; Argani P; Epstein JI; Netto GJ
Urology; 2011 Aug; 78(2):474.e1-5. PubMed ID: 21705046
[TBL] [Abstract][Full Text] [Related]
35. Somatic Mutations of TSC2 or MTOR Characterize a Morphologically Distinct Subset of Sporadic Renal Cell Carcinoma With Eosinophilic and Vacuolated Cytoplasm.
Chen YB; Mirsadraei L; Jayakumaran G; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE
Am J Surg Pathol; 2019 Jan; 43(1):121-131. PubMed ID: 30303819
[TBL] [Abstract][Full Text] [Related]
36. Mixed adenoneuroendocrine carcinoma of gastrointestinal tract: report of two cases.
Gurzu S; Kadar Z; Bara T; Bara T; Tamasi A; Azamfirei L; Jung I
World J Gastroenterol; 2015 Jan; 21(4):1329-33. PubMed ID: 25632209
[TBL] [Abstract][Full Text] [Related]
37. Renal medullary carcinoma: an aggressive neoplasm in patients with sickle cell trait.
Pickhardt PJ
Abdom Imaging; 1998; 23(5):531-2. PubMed ID: 9841069
[TBL] [Abstract][Full Text] [Related]
38. [SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].
Agaimy A; Hartmann A
Pathologe; 2021 Nov; 42(6):571-577. PubMed ID: 34609565
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma with rhabdoid features.
Gökden N; Nappi O; Swanson PE; Pfeifer JD; Vollmer RT; Wick MR; Humphrey PA
Am J Surg Pathol; 2000 Oct; 24(10):1329-38. PubMed ID: 11023094
[TBL] [Abstract][Full Text] [Related]
40. Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
Schaeffer EM; Guzzo TJ; Furge KA; Netto G; Westphal M; Dykema K; Yang X; Zhou M; Teh BT; Pavlovich CP
BJU Int; 2010 Jul; 106(1):62-5. PubMed ID: 20002663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]